A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
Launched by HOFFMANN-LA ROCHE · May 27, 2009
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patients, 18-75 years of age;
- • type 2 diabetes mellitus;
- • treated with stable sulfonylurea monotherapy or metformin + sulfonylurea for \>=12 weeks prior to screening;
- • HbA1c \>=7.0% and \<=10% at screening;
- • stable weight +/-5% for \>=12 weeks prior to screening.
- Exclusion Criteria:
- • type 1 diabetes, diabetes resulting from pancreatic injury, or secondary forms of diabetes;
- • clinically significant diabetic complications;
- • clinically symptomatic gastrointestinal disease;
- • \>3 episodes of severe hypoglycemia within 6 months before screening.
About Hoffmann La Roche
Hoffmann-La Roche, commonly known as Roche, is a global leader in biotechnology and pharmaceuticals, committed to advancing healthcare through innovative research and development. With a strong focus on oncology, immunology, infectious diseases, and central nervous system disorders, Roche leverages cutting-edge science to deliver transformative therapies and diagnostics. The company is dedicated to improving patient outcomes by conducting rigorous clinical trials and collaborating with healthcare professionals and organizations worldwide. Roche's unwavering commitment to precision medicine and personalized healthcare positions it at the forefront of the industry, driving progress in the quest for effective treatments and improved patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Metairie, Louisiana, United States
Winston Salem, North Carolina, United States
Chicago, Illinois, United States
Philadelphia, Pennsylvania, United States
Krakow, , Poland
Lublin, , Poland
Barcelona, , Spain
New York, New York, United States
Wroclaw, , Poland
Moscow, , Russian Federation
Chicago, Illinois, United States
Richmond, Virginia, United States
Springfield, Illinois, United States
Salt Lake City, Utah, United States
Essen, , Germany
Atlanta, Georgia, United States
Houston, Texas, United States
Spokane, Washington, United States
Berlin, , Germany
Medford, Oregon, United States
Dallas, Texas, United States
South Burlington, Vermont, United States
Los Angeles, California, United States
Fargo, North Dakota, United States
Monterrey, , Mexico
Durham, North Carolina, United States
Songkla, , Thailand
Trenton, New Jersey, United States
Besancon, , France
Camperdown, New South Wales, Australia
Chiang Mai, , Thailand
Poitiers, , France
Roswell, Georgia, United States
Lille, , France
Birmingham, , United Kingdom
Bethesda, Maryland, United States
Saint Petersburg, , Russian Federation
Evansville, Indiana, United States
Jackson, Mississippi, United States
Salt Lake City, Utah, United States
Vancouver, Washington, United States
Berlin, New Jersey, United States
Columbus, Georgia, United States
Bend, Oregon, United States
Mainz, , Germany
Coral Gables, Florida, United States
Spokane, Washington, United States
Brick, New Jersey, United States
Minneapolis, Minnesota, United States
Kingsport, Tennessee, United States
Berlin, New Jersey, United States
Barakaldo, Vizcaya, Spain
Oviedo, Asturias, Spain
Guadalajara, Jalisco, Mexico
Winter Park, Florida, United States
Beaver, Pennsylvania, United States
Kiev, , Ukraine
Daytona Beach, Florida, United States
Chiefland, Florida, United States
Cuernavaca, , Mexico
Mexico City, , Mexico
Glasgow, , United Kingdom
Madisonville, Kentucky, United States
Roseville, California, United States
Wollongong, New South Wales, Australia
Waltham, Massachusetts, United States
Buena Park, California, United States
Santa Ana, California, United States
Pamplona, Navarra, Spain
Atherstone, , United Kingdom
Olive Branch, Mississippi, United States
Bratislava, , Slovakia
Conyers, Georgia, United States
Corbeil Essonnes, , France
Wangen, , Germany
Rancho Cucamonga, California, United States
Panama City, Florida, United States
Toms River, New Jersey, United States
Biloxi, Mississippi, United States
Grand Island, Nebraska, United States
Venissieux, , France
Pathumthani, , Thailand
Scranton, Pennsylvania, United States
Odessa, , Ukraine
Sao Paulo, Sp, Brazil
Ayer, Massachusetts, United States
Etobicoke, Ontario, Canada
Thornhill, Ontario, Canada
Mooresville, North Carolina, United States
Staten Island, New York, United States
London, Ontario, Canada
Dommartin Les Toul, , France
Falkensee, , Germany
Münster, , Germany
Auckland, , New Zealand
S.Petersburg, , Russian Federation
Saratov, , Russian Federation
St. Petersburg, , Russian Federation
Cape Town, , South Africa
Almeria, , Spain
La Rochelle, , France
Chino, California, United States
Ferndale, Michigan, United States
San Isidro, , Peru
Levice, , Slovakia
Belo Horizonte, Mg, Brazil
Sulzbach Rosenberg, , Germany
Gdansk, , Poland
Hinckley, , United Kingdom
Reading, , United Kingdom
Waukesha, Wisconsin, United States
Chesterfield, , United Kingdom
Dumfries, , United Kingdom
Toronto, Ontario, Canada
Port Charlotte, Florida, United States
St Petersburg, Florida, United States
Fortaleza, Ce, Brazil
Lago Sul, Df, Brazil
Marilia, Sp, Brazil
Sorocaba, Sp, Brazil
Vancouver, British Columbia, Canada
San Jose, , Costa Rica
Rodgau, , Germany
Siegen, , Germany
Aguascaliente, , Mexico
Celaya, , Mexico
Rio Piedras, , Puerto Rico
Penza, , Russian Federation
Voronezh, , Russian Federation
Yaroslavl, , Russian Federation
Dolny Kubin, , Slovakia
Vinnitsa, , Ukraine
Patients applied
Trial Officials
Clinical Trials
Study Director
Hoffmann-La Roche
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials